$7.960
-0.390 (-4.90%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ATRA por análisis de gráficos similares
Alphio's ATRA stock price prediction model matches the current Atara Biotherapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.95 (-0.16%). The 1-week path is $7.85 (-1.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Atara Biotherapeutics, Inc.?
Atara Biotherapeutics is currently not a strong buy due to mixed signals. The current price is $8.59, which is significantly below its 52-week high of $19.14, indicating a potential for recovery. However, the RSI is at 47.79, suggesting the stock is neither overbought nor oversold. The forward P/E ratio is 15.15, which is reasonable, but the company has a negative net income margin of -767.30% in Q2 2026, indicating ongoing financial struggles. The recent insider selling has increased by 29504.54%, which raises concerns about insider confidence. Therefore, while there are some positive catalysts, such as potential FDA approval, the risks outweigh the benefits at this time.
ATRA cerró en $7.96 el Thursday, tras bajar -4.90%
Atara Biotherapeutics, Inc. (ATRA) last closed at $7.96, losing -4.90%. These facts feed the 1-day and 1-week ATRA price prediction above.
Consenso de analistas
Atara Biotherapeutics, Inc. (ATRA): 4 comprar, 1 mantener, 1 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Atara Biotherapeutics, Inc. (ATRA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ATRA, ordenadas por similitud.
Análisis de estacionalidad de ATRA
Historically the probability of a positive November return for ATRA is 20.93%. December offers the highest probability of a positive month at 74.42%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ATRA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $9.89 | $14.45 | $20.17 | +81.49% |
| Dec 2026 | $8.33 | $15.01 | $19.93 | +88.62% |
En 2026, se proyecta que Atara Biotherapeutics, Inc. (ATRA) oscile entre $8.33 y $20.17.
Previsión mensual de Atara Biotherapeutics, Inc. para 2026
En Nov de 2026, se proyecta que Atara Biotherapeutics, Inc. promedie $14.45, con un mínimo de $9.89 y un máximo de $20.17.
En Dec de 2026, se proyecta que Atara Biotherapeutics, Inc. promedie $15.01, con un mínimo de $8.33 y un máximo de $19.93.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.